[go: up one dir, main page]

YU48102B - Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen - Google Patents

Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen

Info

Publication number
YU48102B
YU48102B YU184790A YU184790A YU48102B YU 48102 B YU48102 B YU 48102B YU 184790 A YU184790 A YU 184790A YU 184790 A YU184790 A YU 184790A YU 48102 B YU48102 B YU 48102B
Authority
YU
Yugoslavia
Prior art keywords
active
flaster
procedure
making
material containing
Prior art date
Application number
YU184790A
Other languages
English (en)
Other versions
YU184790A (sh
Inventor
H.R. Hoffmann
R.P. Klein
R. Meconi
G. Cordes
H.M. Wolff
Original Assignee
Lts. Lohmann Therapie-Systeme Gmbh. & Co. Kg.
Schwarz Pharma Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU48102(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts. Lohmann Therapie-Systeme Gmbh. & Co. Kg., Schwarz Pharma Ag. filed Critical Lts. Lohmann Therapie-Systeme Gmbh. & Co. Kg.
Priority to SI9011847A priority Critical patent/SI9011847B/sl
Publication of YU184790A publication Critical patent/YU184790A/sh
Priority to HR930676A priority patent/HRP930676B1/xx
Publication of YU48102B publication Critical patent/YU48102B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/12—Stiffening bandages containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Adhesive Tapes (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

POSTUPAK ZA IZRADU FLASTERA SA AKTIVNOM MATERIJOM KOJI SADRŽI ESTROGEN za kontrolisano odavanje aktivnih materija na kožu, koji se sastoji od zadnjeg sloja i u vodi nerastvornog lepljivog filma od lepka za prianjanje sa tim spojen, koji sadrži polimere koji mogu da bubre u vodi i u kome je aktivna materija bar delimično rastvorna, i iz zaštitnog sloja koji može ponovo da se odvoji koji pokriva lepljivi film, naznačen time, što se lepljiva masa na bazi homo-i/ili kopolimera homogenizuje sa bar jednim derivatom akrilne ili metakrilne kiseline, pri čemu se kao predhodno ili jednovremeno dodata aktivna materija upotrebljavaju estrogeni i njihovi farmaceutski prihvatljivi derivati sami ili u kombinaciji sa gestagenima, što se masa nanosi na ponovo odvojivi zaštitni sloj ili odvojiv međusloj i posle otparavanja rastvarača pokriva za aktivnu materiju nepropusnim zadnjim slojem. Prijava sadrži još 10 zavisnih zahteva.
YU184790A 1989-10-06 1990-10-01 Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen YU48102B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9011847A SI9011847B (sl) 1989-10-06 1990-10-01 Postopek za izdelavo obliža z dejavno snovjo, vsebujočega estrogen
HR930676A HRP930676B1 (en) 1989-10-06 1993-04-01 Process for the production of an active substance plaster containing estrogen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3933460A DE3933460A1 (de) 1989-10-06 1989-10-06 Oestrogenhaltiges wirkstoffpflaster

Publications (2)

Publication Number Publication Date
YU184790A YU184790A (sh) 1992-12-21
YU48102B true YU48102B (sh) 1997-03-07

Family

ID=6390993

Family Applications (1)

Application Number Title Priority Date Filing Date
YU184790A YU48102B (sh) 1989-10-06 1990-10-01 Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen

Country Status (26)

Country Link
US (1) US5393529A (sh)
EP (1) EP0421454B2 (sh)
JP (1) JP2766864B2 (sh)
KR (1) KR960004300B1 (sh)
AT (1) ATE126069T1 (sh)
AU (1) AU637637B2 (sh)
CA (1) CA2027053C (sh)
CZ (1) CZ282363B6 (sh)
DE (2) DE3933460A1 (sh)
DK (1) DK0421454T3 (sh)
ES (1) ES2078929T5 (sh)
FI (1) FI100380B (sh)
GR (2) GR3017851T3 (sh)
HR (1) HRP930676B1 (sh)
HU (1) HU206831B (sh)
IE (1) IE72141B1 (sh)
IL (1) IL95776A (sh)
MY (1) MY106628A (sh)
NO (1) NO303321B1 (sh)
NZ (1) NZ235581A (sh)
PL (1) PL165270B1 (sh)
PT (1) PT95505B (sh)
SI (1) SI9011847B (sh)
SK (1) SK279514B6 (sh)
YU (1) YU48102B (sh)
ZA (1) ZA907969B (sh)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
DE4223360C1 (sh) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4230588C1 (de) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
DE4237453C1 (sh) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4319096C1 (de) * 1993-06-08 1994-09-08 Kuhl Herbert Prof Dr Phil Nat Hormonales Mittel zur Vorbeugung und Behandlung arterieller Erkrankungen beim Mann
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
DE4403487C2 (de) * 1994-02-04 2003-10-16 Lohmann Therapie Syst Lts Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
JP3534775B2 (ja) * 1995-06-07 2004-06-07 オーソ―マクニール ファーマシューティカル，インコーポレイテッド １７−デアセチルノルゲスチマートを単独でまたはエストロゲンと組み合わせて投与するための経皮パッチおよび方法
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
DE19533089C1 (de) 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
AU732803B2 (en) * 1996-01-17 2001-05-03 National Starch And Chemical Investment Holding Corporation Adhesives resistant to skin-penetration enhancers
DE19700913C2 (de) 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6555217B1 (en) * 1998-06-05 2003-04-29 Henkel Kommanditgesellschaft Auf Aktien Self-supporting and redetachable adhesive article
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
CA2373171A1 (en) * 2000-03-07 2001-09-13 Teijin Limited Stretch plaster
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
EP1334724A4 (en) * 2000-10-16 2007-05-02 Hisamitsu Pharmaceutical Co COMPOSITIONS FOR TOPICAL PREPARATIONS
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
KR100448469B1 (ko) * 2001-10-26 2004-09-13 신풍제약주식회사 항염증제의 경피 조성물 및 장치
DE10157745A1 (de) * 2001-11-24 2003-06-26 Hf Arzneimittelforsch Gmbh Transdermales therapeutisches System zur Verabreichung von 17alpha-Estradiol
JP4295467B2 (ja) * 2002-04-12 2009-07-15 日東電工株式会社 貼付剤およびその製造方法
JP4323138B2 (ja) * 2002-06-05 2009-09-02 日東電工株式会社 経皮吸収型製剤およびその製造方法
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
JP5027373B2 (ja) * 2002-08-09 2012-09-19 帝國製薬株式会社 エストラジオール含有貼付剤
KR101144026B1 (ko) * 2002-08-09 2012-05-09 후소 야쿠힝 고교 가부시끼가이샤 여성 호르몬 함유 부착제
JP4919573B2 (ja) * 2002-08-09 2012-04-18 帝國製薬株式会社 ノルエチステロン含有外用貼付剤
EP1426049B1 (en) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20040208917A1 (en) * 2003-04-16 2004-10-21 Wilfried Fischer Transdermal systems for the release of clonidine
ITMI20041492A1 (it) 2004-07-23 2004-10-23 Italiano Biochimico Far Maceut Nuovo dispositivo per il rilascio di principi attivi
KR100663163B1 (ko) 2005-10-24 2007-01-02 (주)아모레퍼시픽 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
WO2008103673A1 (en) 2007-02-19 2008-08-28 Plurogen Therapeutics, Inc. Compositions for treating biofilms and methods for using same
EP2167045B1 (en) 2007-06-08 2017-08-09 University of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
CN101801321B (zh) 2007-07-10 2014-07-02 敏捷治疗公司 原位密封的经皮输送装置
WO2009009651A1 (en) * 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld
US20100178323A1 (en) 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
ES2795455T3 (es) 2008-10-08 2020-11-23 Agile Therapeutics Inc Suministro transdérmico
CA2740004A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2343963B1 (en) 2008-10-08 2019-04-10 Agile Therapeutics, Inc. Transdermal delivery
US9198920B2 (en) 2009-03-27 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
US8980243B2 (en) 2009-05-19 2015-03-17 Neal Koller Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing at a site of treatment
JP5652867B2 (ja) * 2009-11-20 2015-01-14 日東電工株式会社 医療用粘着剤組成物
EP2377540A1 (en) 2010-03-31 2011-10-19 Hexal AG Transdermal patch containing 17-deacetyl norgestimate
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9822257B2 (en) 2012-07-23 2017-11-21 Crayola Llc Dissolvable films and methods of using the same
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2676288C2 (ru) 2013-12-31 2018-12-27 Джонсон энд Джонсон Консьюмер Инк. Способ формирования многослойного формованного пленочного продукта в один проход
KR102226590B1 (ko) 2013-12-31 2021-03-12 존슨 앤드 존슨 컨수머 인코포레이티드 형상화된 필름 제품을 형성하기 위한 방법
US20150182992A1 (en) 2013-12-31 2015-07-02 Johnson & Johnson Consumer Companies, Inc. Process for forming a multilayered shaped film product
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
AU2015316523A1 (en) 2014-09-18 2017-05-04 Neuroderm, Ltd. Opipramol patch
EP3247364A4 (en) 2015-01-20 2018-10-24 Plurogen Therapeutics, LLC Compositions and methods of treating microbes
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
DE102018120506A1 (de) 2017-10-20 2019-04-25 Amw Gmbh Stabilisiertes transdermales Darreichungssystem
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6902314A (sh) * 1969-02-13 1970-08-17
US3993815A (en) * 1974-10-07 1976-11-23 Avery Products Corporation Anaerobic pressure sensitive adhesive stocks
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPS5620515A (en) * 1979-07-30 1981-02-26 Suzuki Nihondou:Kk Preparation of plaster
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
IN155486B (sh) * 1981-03-16 1985-02-09 Johnson & Johnson Prod Inc
AU553343B2 (en) * 1981-08-10 1986-07-10 Advance Electrode Kabushikikaisya Absorbent adhesive bandage with medicament release
JPS59175419A (ja) * 1983-03-25 1984-10-04 Nitto Electric Ind Co Ltd 外用部材
JPS60123417A (ja) * 1983-12-07 1985-07-02 Nitto Electric Ind Co Ltd 薬物投与部材
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
ATE95430T1 (de) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
JPS61155320A (ja) * 1984-12-28 1986-07-15 Taisho Pharmaceut Co Ltd 貼付剤
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
CH674618A5 (sh) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US4789547A (en) * 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system

Also Published As

Publication number Publication date
IE72141B1 (en) 1997-03-26
GR3033662T3 (en) 2000-10-31
ZA907969B (en) 1991-08-28
IE903572A1 (en) 1991-04-10
PT95505A (pt) 1991-08-14
HUT56290A (en) 1991-08-28
CA2027053C (en) 1998-04-28
AU637637B2 (en) 1993-06-03
EP0421454B1 (de) 1995-08-09
NZ235581A (en) 1993-03-26
CZ282363B6 (cs) 1997-07-16
SI9011847A (sl) 1998-06-30
PL165270B1 (pl) 1994-12-30
MY106628A (en) 1995-06-30
CA2027053A1 (en) 1991-04-07
FI100380B (fi) 1997-11-28
HRP930676A2 (en) 1994-10-31
EP0421454A3 (en) 1991-06-12
HU206831B (en) 1993-01-28
IL95776A0 (en) 1991-06-30
DK0421454T3 (da) 1995-08-09
CS9004859A2 (en) 1991-10-15
HRP930676B1 (en) 2000-10-31
DE3933460C2 (sh) 1992-03-26
JPH03204811A (ja) 1991-09-06
NO904338D0 (no) 1990-10-05
KR910007548A (ko) 1991-05-30
PT95505B (pt) 2001-04-30
ATE126069T1 (de) 1995-08-15
DE3933460A1 (de) 1991-04-18
DE59009495D1 (de) 1995-09-14
ES2078929T5 (es) 2000-08-16
KR960004300B1 (en) 1996-03-30
HU906356D0 (en) 1991-04-29
GR3017851T3 (en) 1996-01-31
SI9011847B (sl) 1999-08-31
NO303321B1 (no) 1998-06-29
FI904888A0 (fi) 1990-10-04
NO904338L (no) 1991-04-08
AU6312890A (en) 1991-04-11
EP0421454B2 (de) 2000-04-05
JP2766864B2 (ja) 1998-06-18
EP0421454A2 (de) 1991-04-10
YU184790A (sh) 1992-12-21
IL95776A (en) 1994-10-07
SK279514B6 (sk) 1998-12-02
US5393529A (en) 1995-02-28
ES2078929T3 (es) 1996-01-01
PL287200A1 (en) 1991-08-12

Similar Documents

Publication Publication Date Title
YU48102B (sh) Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen
AU614209B2 (en) Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof
US5820878A (en) Percutaneously absorbable patch
DK179688D0 (da) Transdermale terapeutiske systemer for kombinationer af aktive stoffer
KR900015761A (ko) 경피성 단일체 시스템
CA2066249C (en) Estradiol percutaneous administration preparations
HUT74455A (en) Pharmaceutical composition containing estradiol penetration intensifier agent for transdermal administration
NZ233152A (en) Transdermal therapeutic system
YU226090A (sh) Postupak za izradu transdermalnog terapijskog sistema sa buprenorphinom kao aktivnim sastojkom
NO950051L (no) Plaster for lavtsmeltende og/eller flyktige aktive bestanddeler
SK279112B6 (sk) Spôsob výroby transdermálneho terapeutického systé
NO309891B1 (no) Transdermalt terapeutisk system og fremgangsmÕte for fremstilling derav
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
NO972565D0 (no) Estradiolholdig plaster
WO1994008571A3 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
YU14394A (sh) Flaster sa aktivnom supstancom za davanje estradiola na kožu
SI9300387B (sl) Transdermalni terapevtski sistem z aktivno snovjo 17-beta-estradiolom (brezvodnim)
YU48663B (sh) Flaster koji sadrži nitroglicerin i postupak za njegovo dobijanje
JPS5770817A (en) Polytice and its preparation
DE4405899A1 (de) Mittel zur transdermalen Applikation enthaltend Desogestrel
EP0865274A2 (de) Flächenstabilisierte pharmazeutische zubereitung zur anwendung auf der haut
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.
JPS577412A (en) Plaster
JPS5742618A (en) Plaster and its preparation
JPS56139424A (en) Adhesive agent